Tullis Health Investors

Tullis Health Investors is a private equity firm founded in 1986, focusing exclusively on healthcare investments. The firm operates two primary funds: Tullis-Dickerson Capital Focus and Tullis Opportunity Funds, managing approximately $400 million in capital. Their investment strategy encompasses a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, healthcare services, and healthcare technology. The firm provides capital from seed through late-stage funding, aiming to build real companies with long-term value.

The firm's portfolio includes notable companies such as Exagen Diagnostics Inc., a provider of autoimmune testing, and Channel Medsystems, a medical device company specializing in women's health. Tullis Health Investors has a history of backing market leaders and has been involved in over 50 private venture capital stage healthcare companies. Their approach emphasizes repeatable, scalable, and commercial healthcare investing, focusing on high-margin, high-growth, novel products and services.

Tullis Health Investors is headquartered in Palm Beach Gardens, Florida, and has a team with extensive experience in healthcare investing. The firm's leadership includes individuals with backgrounds in corporate development, strategic planning, and healthcare investment research. Their commitment to the healthcare sector is demonstrated through their diverse portfolio and active involvement in the growth and development of their investee companies.